Browsing by Author "Sharma, Shobhit"
- Results Per Page
- Sort Options
Item Open Access Development and Application of Simulation Tools for Virtual Imaging Trials in Computed Tomography(2022) Sharma, ShobhitVirtual imaging trials (VITs) utilize anatomically accurate computational models of human subjects and validated imaging simulators for evaluating and optimizing existing and upcoming clinical imaging technologies. By eliminating the logistics of organizing clinical trials, providing full access to ground-truth information, and mitigating ethical considerations relating to exposure of real human subjects to ionizing radiation, VITs significantly improve upon the time- and cost- effectiveness of traditional trials. For VITs in computed tomography (CT), hybrid simulations approaches combining ray-tracing for simulating the primary and Monte Carlo (MC) simulations for the simulating the scattered component of the signal with radiation dose have proven effective for simulating realistic images. Although an effective methodology for simulating images, it requires obtaining realistic scanner-specific estimates of radiation dose and projection-specific scatter in a time-efficient manner, which existing solutions fail to provide.In awareness of these limitations, the purpose of this Ph.D. dissertation was to develop, validate, and apply simulation tools for enabling hybrid imaging simulations for VITs in CT. The research introduced in this dissertation included the following parts: (1) development and validation of a GPU-accelerated Monte Carlo tool for rapid dose and scatter estimation in conventional single source energy-integrating CT, (2) extension of the GPU-accelerated MC tool to model advanced CT systems – dual source CT and photon-counting CT, and (3) demonstrating the utility of the developed simulation tools for specific VIT applications. The dissertation also demonstrated the potential of these tools developed specifically for CT imaging to enable VITs for other x-ray-based imaging modalities. In part 1, a GPU-accelerated Monte Carlo (MC) tool for rapid estimation of dose and scatter estimation in energy-integrating CT was developed. The dose estimates from the tool were validated against measurements of absorbed dose with thermoluminescent dosimeters (TLDs) in anthropomorphic phantoms while the scatter estimates were validated against scatter-to-primary ratios measured using the single-blocker method implemented with a lead cylinder and a CTDI phantom. The developed MC tool combined with kernel- and CNN-based denoising methods was integrated with a ray-tracing imaging simulator to establish a framework for simulating realistic scanner-specific images and organ doses in energy-integrating CT. In part 2, the GPU-accelerated MC tool was extended to model advanced CT systems such as dual-source and photon-counting CT. The modeling of dual-source CT involved the incorporation of a second source-detector pair enabling estimation of cross-scatter. For modeling the physics of image acquisition in photon-counting CT (PCCT), a modular detector response model accounting for the physics of signal generation and effects of non-idealities such as x-ray crosstalk, charge sharing, and pulse pileup in a variety of CdTe- and Si-based photon-counting detectors was developed and validated. The detector response model was integrated with the imaging framework developed in part 1 using spatio-energetic mean and covariance matrices for computing the mean signal and noise in PCCT images. In part 3, the simulation tools developed in parts 1 and 2 were applied to specific VIT applications. The first application involved the assessment of task-specific benefits from improved spatial resolution of a prototype silicon-based PCCT system in context of perceptual benefits across a variety of anatomies (lung, liver, head-and-neck, and inner auditory canal) and radiomics estimation for lung lesions. The second application involved evaluating the impact of low kV imaging on skin dose in contrast-enhanced CT. In addition to CT, the simulation tools developed in this framework were also extended to digital tomosynthesis, where a comprehensive database of organ dose coefficients for adult and pediatric patients across multiple exam protocols was developed for prospective and retrospective clinical organ dosimetry. In conclusion, the research introduced and presented in this dissertation successfully accomplished the development, validation, and application of simulation tools for hybrid imaging simulations for VITs in CT while also demonstrating the potential of the tools developed for enabling VITs in other x-ray-based imaging modalities.
Item Open Access Dose coefficients for organ dosimetry in tomosynthesis imaging of adults and pediatrics across diverse protocols.(Medical physics, 2022-06-11) Sharma, Shobhit; Kapadia, Anuj; Ria, Francesco; Segars, W Paul; Samei, EhsanPurpose
The gold-standard method for estimation of patient-specific organ doses in digital tomosynthesis (DT) requires protocol-specific Monte Carlo (MC) simulations of radiation transport in anatomically accurate computational phantoms. Although accurate, MC simulations are computationally expensive, leading to a turnaround time in the order of core hours for simulating a single exam. This limits their clinical utility. The purpose of this study is to overcome this limitation by utilizing patient- and protocol-specific MC simulations to develop a comprehensive database of air-kerma-normalized organ dose coefficients for a virtual population of adult and pediatric patient models over an expanded set of exam protocols in DT for retrospective and prospective estimation of radiation dose in clinical tomosynthesis.Materials and methods
A clinically representative virtual population of 14 patient models was used, with pediatric models (M and F) at ages 1, 5, 10, and 15 and adult patient models (M and F) with BMIs at 10th , 50th , and 90th percentiles of the US population. A GPU-based MC simulation framework was used to simulate organ doses in the patient models, incorporating the scanner-specific configuration of a clinical DT system (VolumeRad, GE Healthcare, Waukesha, WI) and an expanded set of exam protocols including 21 distinct acquisition techniques for imaging a variety of anatomical regions (head and neck, thorax, spine, abdomen, and knee). Organ dose coefficients (hn ) were estimated by normalizing organ dose estimates to air kerma at 70 cm (X70cm ) from the source in the scout view. The corresponding coefficients for projection radiography were approximated using organ doses estimated for the scout view. The organ dose coefficients were further used to compute air-kerma-normalized patient-specific effective dose coefficients (Kn ) for all combinations of patients and protocols, and a comparative analysis examining the variation of radiation burden across sex, age, and exam protocols in DT, and with projection radiography was performed.Results
The database of organ dose coefficients (hn ) containing 294 distinct combinations of patients and exam protocols was developed and made publicly available. The values of Kn were observed to produce estimates of effective dose in agreement with prior studies and consistent with magnitudes expected for pediatric and adult patients across the different exam protocols, with head and neck regions exhibiting relatively lower and thorax and C-spine (apsc, apcs) regions relatively higher magnitudes. The ratios (r = Kn /Kn,rad ) quantifying the differences air-kerma-normalized patient-specific effective doses between DT and projection radiography were centered around 1.0 for all exam protocols, with the exception of protocols covering the knee region (pawk, patk).Conclusions
This study developed a database of organ dose coefficients for a virtual population of 14 adult and pediatric XCAT patient models over a set of 21 exam protocols in DT. Using empirical measurements of air kerma in the clinic, these organ dose coefficients enable practical retrospective and prospective patient-specific radiation dosimetry. The computation of air-kerma-normalized patient-specific effective doses further enable the comparison of radiation burden to the patient populations between protocols and between imaging modalities (e.g., DT and projection radiography), as presented in this study. This article is protected by copyright. All rights reserved.Item Open Access Organ doses from CT localizer radiographs: Development, validation, and application of a Monte Carlo estimation technique(MEDICAL PHYSICS, 2019-11-01) Hoye, Jocelyn; Sharma, Shobhit; Zhang, Yakun; Fu, Wanyi; Ria, Francesco; Kapadia, Anuj; Segars, W Paul; Wilson, Joshua; Samei, EhsanItem Open Access Organ Doses from CT Localizer Radiographs: Development, Validation, and Application of a Monte Carlo Estimation Technique.(Medical physics, 2019-08-23) Hoye, Jocelyn; Sharma, Shobhit; Zhang, Yakun; Fu, Wanyi; Ria, Francesco; Kapadia, Anuj; Segars, W Paul; Wilson, Joshua; Samei, EhsanPURPOSE:The purpose of this study was to simulate and validate organ doses from different CT localizer radiograph geometries using Monte Carlo methods for a population of patients. METHODS:A Monte Carlo method was developed to estimate organ doses from CT localizer radiographs using PENELOPE. The method was validated by comparing dosimetry estimates with measurements using an anthropomorphic phantom imbedded with thermoluminescent dosimeters (TLDs) scanned on a commercial CT system (Siemens SOMATOM Flash). The Monte Carlo simulation platform was then applied to conduct a population study with fifty-seven adult computational phantoms (XCAT). In the population study, clinically relevant chest localizer protocols were simulated with the x-ray tube in anterior-posterior (AP), right lateral, and PA positions. Mean organ doses and associated standard deviations (in mGy) were then estimated for all simulations. The obtained organ doses were studied as a function of patient chest diameter. Organ doses for breast and lung were compared across different views and represented as a percentage of organ doses from rotational CT scans. RESULTS:The validation study showed an agreement between the Monte Carlo and physical TLD measurements with a maximum percent difference of 15.5% and a mean difference of 3.5% across all organs. The XCAT population study showed that breast dose from AP localizers was the highest with a mean value of 0.24 mGy across patients, while the lung dose was relatively consistent across different localizer geometries. The organ dose estimates were found to vary across the patient population, partially explained by the changes in the patient chest diameter. The average effective dose was 0.18 mGy for AP, 0.09 mGy for lateral, and 0.08 mGy for PA localizer. CONCLUSION:A platform to estimate organ doses in CT localizer scans using Monte Carlo methods was implemented and validated based on comparison with physical dose measurements. The simulation platform was applied to a virtual patient population, where the localizer organ doses were found to range within 0.4-8.6% of corresponding organ doses for a typical CT scan, 0.2-3.3% of organ doses for a CT pulmonary angiography scan, and 1.1-20.8% of organ doses for a low dose lung cancer screening scan.